Holdings
Thrivent Healthcare Portfolio
As of Jun 30, 2026, Thrivent Healthcare Portfolio reported 42 positions worth US$235M. Largest: Eli Lilly And Company, Johnson & Johnson and Abbvie Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 31,178 | US$37.4M | −567 | Jun 30, 2026 |
| Johnson & Johnson | 84,431 | US$21.4M | −1,929 | Jun 30, 2026 |
| Abbvie Inc. | 64,475 | US$16.2M | −6,039 | Jun 30, 2026 |
| Unitedhealth Group Incorporated | 38,374 | US$15.9M | −2,690 | Jun 30, 2026 |
| Merck & Company, Inc. | 77,482 | US$9.96M | −25,014 | Jun 30, 2026 |
| Stryker Corporation | 28,542 | US$8.99M | +3,134 | Jun 30, 2026 |
| Danaher Corporation | 40,038 | US$7.63M | no change | Jun 30, 2026 |
| Amgen Inc. | 19,089 | US$6.91M | −1,274 | Jun 30, 2026 |
| Labcorp Holdings Inc. | 21,785 | US$6.1M | +8,139 | Jun 30, 2026 |
| Cencora, Inc. | 20,389 | US$5.77M | +4,518 | Jun 30, 2026 |